How to buy Durect Corporation stock (DRRX)

Durect Corporation is a drug manufacturers - specialty & generic business based in the US. Durect Corporation shares (DRRX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.95 – an increase of 26.67% over the previous week. Durect Corporation employs 48 staff and has a trailing 12-month revenue of around $8.4 million.

Our top picks for where to buy Durect Corporation stock

Buy Durect Corporation stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Durect Corporation stock price (NASDAQ: DRRX)

Use our graph to track the performance of DRRX stocks over time.

Durect Corporation shares at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$0.95
52-week range	$0.50 - $1.88
50-day moving average more info button	$1.14
200-day moving average more info button	$1.25
Wall St. target price	$6.75
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.64

Is it a good time to buy Durect Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Durect Corporation price performance over time

Historical closes compared with the close of $0.95 from 2024-12-20

1 week (2024-12-13)	26.67%
1 month (2024-11-22)	-5.94%
3 months (2024-09-20)	-29.10%
6 months (2024-06-21)	-37.09%

1 year (2023-12-22)	82.73%
2 years (2022-12-22)	-74.39%
3 years (2021-12-22)	9.701
5 years (2019-12-20)	24.1

Durect Corporation financials

Revenue TTM	$8.4 million
Gross profit TTM	$16.5 million
Return on assets TTM	-39.7%
Return on equity TTM	-299.88%
Profit margin	-187.84%
Book value	$0.49
Market Capitalization more info button	$26.2 million

TTM: trailing 12 months

Durect Corporation share dividends

We're not expecting Durect Corporation to pay a dividend over the next 12 months.

Have Durect Corporation's shares ever split?

Durect Corporation's shares were split on a 1:10 basis on 5 December 2022 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Durect Corporation shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Durect Corporation shares which in turn could have impacted Durect Corporation's share price.

Durect Corporation share price volatility

Over the last 12 months, Durect Corporation's shares have ranged in value from as little as $0.4989 up to $1.88. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Durect Corporation's is 1.133. This would suggest that Durect Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Durect Corporation overview

DURECT Corporation, a biopharmaceutical company, develops medicines based on its epigenetic regulator program. The company's lead product larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. It also offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine over three days in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in other countries. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd. ; and Innocoll Pharmaceuticals Limited.

Frequently asked questions

null
What percentage of Durect Corporation is owned by insiders or institutions?
Currently 5.79% of Durect Corporation shares are held by insiders and 23.004% by institutions. How many people work for Durect Corporation?
Latest data suggests 48 work at Durect Corporation. When does the fiscal year end for Durect Corporation?
Durect Corporation's fiscal year ends in December. Where is Durect Corporation based?
Durect Corporation's address is: 10240 Bubb Road, Cupertino, CA, United States, 95014-4166 What is Durect Corporation's ISIN number?
Durect Corporation's international securities identification number is: US2666051048 What is Durect Corporation's CUSIP number?
Durect Corporation's Committee on Uniform Securities Identification Procedures number is: 266605104